You are here

Article info

Article menu
Oncolytic and local immunotherapy
Original research
Triple-serotype chimeric oncolytic adenovirus exerts multiple synergistic mechanisms against solid tumors

Authors

  • Yinghan Su Department of General Surgery, Huashan Hospital, Cancer Metastasis Institute, Fudan University, Shanghai 200040, ChinaNational Center for Liver Cancer (NCLC), Navy Military Medical University, Shanghai 201805, China PubMed articlesGoogle scholar articles
  • Jiang Li National Center for Liver Cancer (NCLC), Navy Military Medical University, Shanghai 201805, ChinaDepartment of Molecular Oncology, Eastern Hepatobiliary Surgery Hospital, Navy Military Medical University, Shanghai 200438, China PubMed articlesGoogle scholar articles
  • Weidan Ji National Center for Liver Cancer (NCLC), Navy Military Medical University, Shanghai 201805, ChinaDepartment of Molecular Oncology, Eastern Hepatobiliary Surgery Hospital, Navy Military Medical University, Shanghai 200438, China PubMed articlesGoogle scholar articles
  • Gang Wang Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy & Cancer Institute, Xuzhou Medical University, Xuzhou 221002, Jiangsu, China PubMed articlesGoogle scholar articles
  • Lin Fang Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy & Cancer Institute, Xuzhou Medical University, Xuzhou 221002, Jiangsu, China PubMed articlesGoogle scholar articles
  • Qin Zhang Department of Molecular Oncology, Eastern Hepatobiliary Surgery Hospital, Navy Military Medical University, Shanghai 200438, China PubMed articlesGoogle scholar articles
  • Lin Ang Department of Pathology, Second People's Hospital of Hefei, Hefei 230011, Anhui, China PubMed articlesGoogle scholar articles
  • Min Zhao Department of Pathology, Second People's Hospital of Hefei, Hefei 230011, Anhui, China PubMed articlesGoogle scholar articles
  • Yuan Sen Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy & Cancer Institute, Xuzhou Medical University, Xuzhou 221002, Jiangsu, China PubMed articlesGoogle scholar articles
  • Lei Chen National Center for Liver Cancer (NCLC), Navy Military Medical University, Shanghai 201805, ChinaDepartment of Molecular Oncology, Eastern Hepatobiliary Surgery Hospital, Navy Military Medical University, Shanghai 200438, China PubMed articlesGoogle scholar articles
  • Junnian Zheng Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy & Cancer Institute, Xuzhou Medical University, Xuzhou 221002, Jiangsu, China PubMed articlesGoogle scholar articles
  • Changqing Su National Center for Liver Cancer (NCLC), Navy Military Medical University, Shanghai 201805, ChinaDepartment of Molecular Oncology, Eastern Hepatobiliary Surgery Hospital, Navy Military Medical University, Shanghai 200438, ChinaJiangsu Center for the Collaboration and Innovation of Cancer Biotherapy & Cancer Institute, Xuzhou Medical University, Xuzhou 221002, Jiangsu, China PubMed articlesGoogle scholar articles
  • Lunxiu Qin Department of General Surgery, Huashan Hospital, Cancer Metastasis Institute, Fudan University, Shanghai 200040, China PubMed articlesGoogle scholar articles

Citation

Su Y, Li J, Ji W, et al
Triple-serotype chimeric oncolytic adenovirus exerts multiple synergistic mechanisms against solid tumors
Journal for ImmunoTherapy of Cancer 2022;10:e004691. doi: 10.1136/jitc-2022-004691
Online issue publication 
May 24, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.